- Home
- CCAQ vs MIST Comparison
CCAQ vs MIST Comparison
Compare CCAQ & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$1.05
Company Overview
Basic Information| Metric | CCAQ | MIST |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.6M | 176.3M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CCAQ | MIST |
|---|---|---|
| Price | $10.48 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 165.6K | ★ 1.1M |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.43 | $1.00 |
| 52 Week High | $10.48 | $3.06 |
Technical Indicators
Market Signals| Indicator | CCAQ | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 68.96 | 26.25 |
| Support Level | $10.45 | $1.00 |
| Resistance Level | N/A | $1.42 |
| Average True Range (ATR) | 0.01 | 0.06 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 100.00 | 3.00 |
Price Performance
Historical Comparison CCAQ
MIST
About CCAQ Collective Acquisition Corp. Class A Ordinary Shares
Collective Acquisition Corp is a blank check company.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).